Related references
Note: Only part of the references are listed.How I treat ALL in Down's syndrome: pathobiology and management
Shai Izraeli et al.
BLOOD (2014)
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group
Trudy D. Buitenkamp et al.
BLOOD (2014)
Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol
Katharine Patrick et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries
Catarina Lundin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Reduced Intensity Conditioning in Allogeneic Stem Cell Transplantation for AML With Down Syndrome
Hideki Muramatsu et al.
PEDIATRIC BLOOD & CANCER (2014)
Outcome of Transplantation for Acute Lymphoblastic Leukemia in Children With Down Syndrome
Johann K. Hitzler et al.
PEDIATRIC BLOOD & CANCER (2014)
Outcome of Transplantation for Acute Myelogenous Leukemia in Children with Down Syndrome
Johann K. Hitzler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT
M. P. Hudspeth et al.
BONE MARROW TRANSPLANTATION (2013)
Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia
C. Bohnstedt et al.
LEUKEMIA (2013)
Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD
J. Sugita et al.
BONE MARROW TRANSPLANTATION (2012)
Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971
April D. Sorrell et al.
CANCER (2012)
Hematological disorders and leukemia in children with Down syndrome
Annelyse Bruwier et al.
EUROPEAN JOURNAL OF PEDIATRICS (2012)
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
T. D. Buitenkamp et al.
LEUKEMIA (2012)
Myelosuppression and infectious complications in children with down syndrome and acute lymphoblastic leukemia
Karen R. Rabin et al.
PEDIATRIC BLOOD & CANCER (2012)
Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study Group
Hiroaki Goto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Decreased Thymic Output Accounts for Decreased Naive T Cell Numbers in Children with Down Syndrome
Beatrijs L. P. Bloemers et al.
JOURNAL OF IMMUNOLOGY (2011)
Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles
M. G. Loudin et al.
LEUKEMIA (2011)
Continuous and High-Dose Cytarabine Combined Chemotherapy in Children with Down Syndrome and Acute Myeloid leukemia: Report from the Japanese Children's Cancer and Leukemia Study Group (JCCLSG) AML 9805 Down Study
Takashi Taga et al.
PEDIATRIC BLOOD & CANCER (2011)
Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
Mohamad Mohty et al.
BLOOD (2010)
New perspectives on the biology of acute GVHD
S. Paczesny et al.
BONE MARROW TRANSPLANTATION (2010)
Clinical practice The care of children with Down syndrome
Michel E. Weijerman et al.
EUROPEAN JOURNAL OF PEDIATRICS (2010)
Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia
Trudy D. Buitenkamp et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
High incidence of acute lung injury in children with Down syndrome
M. Bruijn et al.
INTENSIVE CARE MEDICINE (2007)
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia
B. Meissner et al.
BONE MARROW TRANSPLANTATION (2007)
Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries:: 1992-2001
MS Christensen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation
E Clave et al.
BLOOD (2005)